NOVELTY – The synthesis of Hyrtios erectus sponge based anti-tumor agents comprises production of (-)-hyrtiosal, (+)-hyrtiosal, (-)-16-epi-hyrtiosal and (+)-16-epi-hyrtiosal from (+/-)-capalic acid in 11 steps. The respective yields are 4.8, 4.2, 6.8 and 6.0 per cent. USE – In industrial chemistry.

Main Application Field

B03 (Other heterocyclics.)

INVENTORS:

IMAMURA PAULO MITSUO
SANTIAGO GILVANDETE MARIA PINH
LUNARDI INES

_

Patent number: BR200202903-A

PATENT STATUS:

For information contact Inova Unicamp

FOR ADDITIONAL INFORMATION:

parcerias@inova.unicamp.br

+55 (19) 3521-5207 / 2607

This technology profile has been automatically generated.